PMTCT, and National's - Health Systems Trust
PMTCT, and National's - Health Systems Trust
PMTCT, and National's - Health Systems Trust
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Proposed Infant HIV Test Timelines<br />
6 weeks 1 st well baby clinic visit<br />
Clinical assessment<br />
HIV DNA PCR test<br />
10 or 14 weeks Timing of 2 nd <strong>and</strong> 3 rd immunization visit<br />
Clinical assessment<br />
HIV DNA PCR result<br />
• PCR positive – child is HIV infected – refer for HIV specific<br />
care, reinforce infant feeding choices + start co-trimoxazole<br />
• PCR negative – mother counseled that child is HIV uninfected<br />
at present <strong>and</strong> educated on feeding practices<br />
Note: test not infallible as breastfeeding <strong>and</strong> other exposure would mean<br />
possible window period infection status {+ specimen mix up possible but<br />
limited (12 months age<br />
AND<br />
• >3 months after breastfeeding has ceased<br />
Positive Children<br />
If no ART <strong>and</strong> no HIV stigmata<br />
• Confirm HIV status by rapid HIV test at 18 months<br />
Note: this test would pick up any children misdiagnosed as positive probably by<br />
specimen mix up at 6 weeks.<br />
Note: It is envisaged that this diagnostic protocol would enable the majority of children (>97%)<br />
to be correctly diagnosed at 6 weeks of age. By reducing the number of children requiring<br />
follow up for HIV by approximately 90% at 10-14 weeks of age, scarce health care resources<br />
can be focused on HIV infected children. Child health care workers would need to maintain<br />
a high index of suspicion in HIV exposed children who present with clinical stigmata of HIV<br />
later on in life in order to diagnose post natal transmission of the virus <strong>and</strong> to refer these<br />
children for appropriate medical management.<br />
Practical Issues Surrounding Implementation of NAT Testing for <strong>PMTCT</strong> follow-up<br />
• The DOH <strong>and</strong> NHLS need to work more closely to leverage their significant, but<br />
currently inefficiently employed, resources to make this diagnostic method deliverable.<br />
• Provinces should be able to decide when to implement alternative testing strategies<br />
depending on their capabilities. In places where rapid tests are not yet available this<br />
should be implemented prior to nucleic acid testing as a basic requirement.<br />
• The same problems experienced already with rapid testing such as stocks running out,<br />
poor quality control, <strong>and</strong> inadequate staff training will occur with an alternative form<br />
of testing. These logistical <strong>and</strong> infrastructural issues should therefore be addressed<br />
before a new method of testing is made widely available otherwise this could worsen<br />
existing services.<br />
• Thorough investigation is needed to determine the adequacy of transport systems to<br />
facilities to enable this form of testing to be undertaken.<br />
• The NHLS laboratory network (>150 nationwide) needs to be exploited <strong>and</strong> staff<br />
trained at all clinics on how to use this system. Currently the NHLS has links to all<br />
antenatal clinics <strong>and</strong> systems in place for transport of specimens to tertiary centers<br />
that have NAT capability. The decision to use NAT would require these logistics to be<br />
effectively mobilized. Currently NAT capability exists in Cape Town, Durban, Bloemfontein,<br />
Johannesburg <strong>and</strong> Pretoria. Consideration to use dried blood spots vs EDTA collection<br />
tubes would need to be investigated. This is a separate discussion that should be held<br />
with the relevant team from the NHLS but is definitely achievable.<br />
32